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DNA Manipulation
Plasmid pYT284 containing the actIII gene was cloned into the pET-28b(+) expression vector (Novagen) (Korman et al., 2004) . All mutants were generated by PCR using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) with wild-type plasmid pYT284 as the template. E. coli strain NovaBlue (Novagen) was used for plasmid amplification. All mutations were confirmed by sequencing.
ActKR Protein Expression and Purification
Following transformation, cells were grown by shaking at 37 °C in 1 L Luria-Bertani media supplemented with 50 μg/mL kanamycin to an OD 600 of 0.6. At that point, protein expression was induced by addition of 0.1 mM IPTG at 18 °C overnight. Cells were harvested by centrifugation at 4 °C, resuspended in 100 mL buffer A (50 mM Tris-Cl pH 7.5, 300 mM NaCl, and 10% glycerol), and lysed on ice by sonication (5 x 30 sec pulses). Cell debris were removed by centrifugation followed by binding of recombinant protein to 5 mL Ni-IMAC resin (Bio-Rad) in batch-mode at 4 °C. 
ActKS-CLF Expression and Purification
Expression of actKS-CLF from Streptomyces coelicolor CH999/pRJC006 spores has been previously described (Matharu et al., 1998) . Briefly, spores were grown in 50 mL Super YEME containing 50 μg/mL kanamycin for 3 days at 30 °C shaking at 250 rpm. Mycelia were then transferred to 500 mL Super YEME containing 50 μg/mL kanamycin and grown as before for 2 days. Protein expression was induced by addition of 5 μg/mL thiostrepton and cell growth continued as before for 1 more day. Cells were harvested by centrifugation, resuspended in 40 mL lysis buffer (100 mM KPi pH 7.5, 0.1% Triton X-100, 5 mM TCEP, 1.5 mM benzamidine, 1 tablet EDTA-free protease inhibitor cocktail [Roche] , and 10% glycerol), and lysed on ice by sonication (8 x 1 min pulses). Cell debris were removed by centrifugation followed by binding of lysate supernatant to 3 mL Ni-IMAC resin (Bio-Rad) in batch-mode at 4 °C. Protein was eluted with increasing concentrations of imidazole in 100 mM KPi pH 7.5, 500 mM NaCl, and 10%
glycerol. Fractions containing actKS-CLF were collected at 150 and 500 mM imidazole, pooled, and buffer-exchanged to 100 mM KPi pH 7.2 and 20% glycerol.
Holo-FrenN ACP and MAT Expression and Purification
E. coli BAP1 cells (Pfeifer et al., 2001 ) expressing pET-21c-frenACP were grown at 37
°C in 1 L Luria-Bertani media supplemented with 100 μg/mL ampicillin to an OD 600 of 0.5. At that point, protein expression was induced by addition of 1 mM IPTG at 18 °C overnight. The initial purification of holo-ACP was conducted as described previously (Li et al., 2003) .
Following phenyl-Sepharose chromatography, ACP was buffer-exchanged to buffer A (50 mM Tris-Cl pH 7.5, 2 mM DTT, 2 mM EDTA, and 10% glycerol). Protein was applied to a HiTrap Q FF column (GE Healthcare) and eluted with a linear gradient from 0-100% buffer B (buffer A plus 1 M NaCl). Fractions containing pure holo-ACP were pooled and concentrated. S.
coelicolor MAT was expressed and purified from E. coli BL21(DE3)/pGFL16 by Ni-IMAC as described previously (Kumar et al., 2003) .
Protein Crystallization and Data Collection
Crystals of the V151L, F189W, and Y202F actKR mutants were grown through sittingdrop vapor diffusion at room temperature. Drops were generated by mixing 2 μL protein solution with 2 μL well buffer in the presence of 500 μL well buffer, with each protein at a concentration of 5 mg/mL. In addition, V151L was crystallized in the presence of 4 mM NADPH and Y202F
in the presence of 4 mM NADPH and 400 μM emodin. Crystals were flash-frozen in 30% glycerol in well solution after harvesting. Data were collected on beamline 8.2.2 at the Advanced Light Source (ALS) to 2.6 Å for V151L and 2.8 Å for both F189W and Y202F. Diffraction intensities were indexed, integrated, and scaled using HKL-2000 (Otwinowski and Minor, 1997) .
Crystal data statistics are listed in the table below.
Phasing by Molecular Replacement and Refinement
Structures were solved by molecular replacement using PHASER in CCP4i (1994) . The previously solved P94L-NADPH actKR structure (PDB ID 3QRW) was used as the search model with formate and waters removed. Following an initial round of refinement with PHENIX (Adams et al., 2010) , manual rebuilding was performed and waters added in COOT (Emsley and Cowtan, 2004) . Refinement was continued until the final R and R free were 0.179 and 0.218 for V151L, 0.188 and 0.246 for F189W, and 0.187 and 0.247 for Y202F. The quality of each final structure was analyzed with PROCHECK (Laskowski et al., 1996) . Refinement and model statistics are listed in the table below.
ACP Fluorescence Binding Assay
To gauge interaction between ACP and either wild-type, R38A, R65A, or R93A actKR, In Vitro trans-1-Decalone Assay for ActKR Activity Table 2 and detailed steady-state data in Table S1 .
In Vitro PKS Reconstitution Assay
To determine C9-ketoreduction activity of wild-type and mutant actKR toward a 16-carbon polyketide substrate to produce mutactin in vitro, 50 μM wild-type or mutant actKR was incubated with 10 μM actKS-CLF, 50 μM holo-frenN ACP, 1 μM MAT, 5 mM malonyl-CoA, and 2 mM NADPH, and the reaction volume brought to 250 μL by addition of 100 mM Tris-Cl (pH 7.0). For the assay of the arginine mutants, 10 μM wild-type or mutant actKR was incubated with 1 μM actKS-CLF, 50 μM holo-actACP, 1 mM malonyl-CoA, 2 mM NADPH, 1 mM TCEP, and 2 mM EDTA, and the reaction volume brought to 100 μL in 100 mM phosphate buffer (pH 7.3). Each reaction was incubated at room temperature overnight followed by extraction with 300 μL of 94% ethyl acetate, 5% methanol, and 1% acetic acid. Solvent was evaporated, products resuspended in 100 μL DMSO, and 20 μL subjected to reverse-phase HPLC analysis on a Synergi Hydro-RP analytical column (Phenomenex, 4 μ, 150 x 4.6 mm) for Tables S3 and S4 for gradient used), monitored at 280 nm.
